Aliada Therapeutics - Ownership and Business Overview

Life ScienceCompany

Aliada Therapeutics Ownership

Who owns Aliada Therapeutics?

Aliada Therapeutics is owned by AbbVie. It was acquired on October 28, 2024.

Aliada Therapeutics Business Overview

Where is Aliada Therapeutics headquartered?

Aliada Therapeutics is headquartered in Boston, Massachusetts.

What sector is Aliada Therapeutics in?

Aliada Therapeutics is a life science company.

Life Science M&A Summary in 2024

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.

Join Mergr to view all 206 acquisitions of life science companies in 2024, including 21 acquisitions by private equity firms, and 185 by strategics.

Aliada Therapeutics

Aliada Therapeutics, Inc.

501 Boylston Street 9th Floor,
Boston, Massachusetts 02116
United States,
www.aliadatx.com

Aliada Therapeutics is a biotechnology company focused on addressing delivery challenges in CNS drug development. Aliada Therapeutics is based in Boston, Massachusetts.


 Subscribe to unlock this and 209,235
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.